59 reports

The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIVAg/ HIV NAT, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets:- Hospitals - Public Health Labs - Commercial/ Privat

  • Ambulatory Care
  • Europe
  • World
  • Demand
  • Market Shares

The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIV Ag, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets:- Hospitals - Public Health Labs - Commercial/ Private Labs - Blo

  • Ambulatory Care
  • Europe
  • France
  • Japan
  • Demand

The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIVAg/ HIV NAT, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets:- Hospitals - Public Health Labs - Commercial/ Privat

  • Ambulatory Care
  • Europe
  • France
  • Japan
  • Demand

The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIV Ag, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets: - Hospitals - Public Health Labs - Commercial/ Private Labs &

  • Ambulatory Care
  • Europe
  • Japan
  • United States
  • Demand

& nbsp; The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIVAg/ HIV NAT, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets:- Hospitals - Public Health Labs - Commercial&

  • Ambulatory Care
  • HIV AIDS
  • Europe
  • Germany
  • Demand

HIV/ AIDS Diagnostic Testing Market, 2021 I.

  • Ambulatory Care
  • Europe
  • France
  • Germany
  • Demand

The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIV Ag, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets:- Hospitals - Public Health Labs - Commercial/ Private Labs - Blo

  • Ambulatory Care
  • HIV AIDS
  • Europe
  • Germany
  • Demand

This can be attributed to the high prevalence of diseases such as HIV/ AIDS, hepatitis, Ebola, caused by viral infections.

  • Ambulatory Care
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

CVDs account for highest patient pool in the country, after HIV/ AIDS.

  • Ambulatory Care
  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Teleflex Incorporated

IT IS A CHRONIC, NON-COMMUNICABLE INFLAMMATORY DISEASE WHICH IS OFTEN MISTAKEN FOR CONTAGIOUS DISEASES, SUCH AS LEPROSY, SYPHILIS AND EVEN HIV/ AIDS.

  • Ambulatory Care
  • Market Size
  • Amgen Inc.
  • Samsung Bioepis Co., Ltd.
  • Sandoz Inc.

Cardiovascular diseases accounts for highest patient pool in the country, after HIV/ AIDS.

  • Ambulatory Care
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Teleflex Incorporated

OTHER COMPANY PERFORMANCE Public Health Solutions Market share: ##. ##% OTHER COMPANY PERFORMANCE Shady Grove Fertility Market share: ##. ##% health, reproductive health, tobacco control and HIV/ AIDS prevention.

  • Ambulatory Care
  • Clinic
  • Health Services
  • United States
  • Forecast

Forward Pharma A/ S (Denmark) ##.

  • Ambulatory Care
  • World
  • Demand
  • Market Competition
  • Market Shares

He is experienced in designing and executing operational research study on HIV/ AIDS services uptake among high risk groups (HRGs) in India.

  • Ambulatory Care
  • Japan
  • Spain
  • United States
  • Forecast

The company offers active pharmaceutical ingredients and formulations in various therapeutic areas including women' s health, cardiovascular, children' s health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, and hepatitis etc.

  • Ambulatory Care
  • India
  • Allergan plc
  • Cipla Ltd
  • Novartis AG

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Ambulatory Care
  • Germany
  • Japan
  • United States
  • Forecast

HE IS EXPERIENCED IN DESIGNING AND EXECUTING OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Ambulatory Care
  • United States
  • Allergan plc
  • Novartis AG
  • Ophthotech Corporation
  • LICENSING AGREEMENTS

Its CAL-## offers cell therapies for HIV AIDS.

  • Ambulatory Care
  • United States
  • Assurex Health, Inc.
  • SEQUOIA CAPITAL OPERATIONS, LLC
  • Sirona Biochem Corp

It concentrates its R& D efforts in the area of diseases with significant unmet medical needs: HIV/ AIDS, oncology, hepatitis, immunologic disorders, and cardiovascular and fibrotic disease.

  • Ambulatory Care
  • Baxter International Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Spectrum Pharmaceuticals, Inc.

AIDS PATIENTS).

  • Ambulatory Care
  • North America
  • United States
  • Allergan plc
  • Neurotech Pharmaceuticals, Inc.

" We are pleased to present our progress and meet investors one-on-one.

  • Ambulatory Care
  • Cell Therapy
  • United States
  • Product Initiative
  • Ohr Pharmaceutical Inc.
  • MANKIND REVENUE BY SEGMENTATION; 2012-2016

Dermatological conditions are one of the most common types of disorders worldwide, affecting approximately more than half of the population. In past decades, the majority of the dermatology market has been saturated with established products; for example, acne has reached its saturation with respect to its biologics and new product pipeline...

  • Ambulatory Care
  • Therapy
  • World
  • Market Size
  • Paratek Pharmaceuticals, Inc.

Patients will subsequently be randomized ##:## at week ## to either continue administering Squalamine Eye Drops or discontinue drops for the remainder of the ##-week study.

  • Ambulatory Care
  • Pharmaceutical
  • United States
  • Product Initiative
  • Ohr Pharmaceutical Inc.
  • PIPELINE BY ALTEOGEN INC, H2 2018

The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/ AIDS, Huntingtons disease, chronic neuropathic pain, cancer immunotherapy and retinitis.

  • Ambulatory Care
  • Ophthalmology
  • United States
  • World
  • Regeneron Pharmaceuticals, Inc.
  • Pipeline by Alteogen Inc, H2 2018

The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/ AIDS, Huntingtons disease, chronic neuropathic pain, cancer immunotherapy and retinitis.

  • Ambulatory Care
  • Targeted Therapy
  • World
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

Vincent' s Hospital' s HIV/ AIDS Center ## Mount Sinai Medical Center Enters Into Research Collaboration With Isilon Systems ## Mount Sinai Forms Joint Venture With Columbia University ## Continuum Health Partners And Mount Sinai Medical Center Complete Merger ## Mou

  • Ambulatory Care
  • Health Services
  • United States
  • Deals & Alliance
  • M&A
  • Pipeline by Benitec Biopharma Ltd, H1 2018
  • Pipeline by Alteogen Inc, H1 2018

The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/ AIDS, Huntingtons disease, chronic neuropathic pain, cancer immunotherapy and retinitis.

  • Ambulatory Care
  • Ophthalmology
  • Therapy
  • World
  • Regeneron Pharmaceuticals, Inc.
  • PIPELINE BY ALTEOGEN INC, H1 2018

The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/ AIDS, Huntington' s disease, chronic neuropathic pain, cancer immunotherapy and retinitis.

  • Ambulatory Care
  • United States
  • World
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • CONTEXT THERAPEUTICS ENTERS INTO PARTNERSHIP WITH CEDARS-SINAI MEDICAL CENTER, FRED HUTCHINSON CANCER RESEARCH CENTER AND SYNERGIE LYON CANCER

Among the recent product approvals which were supported by studies funded by this grants program are a marketing approval for a much-needed treatment of human immunodeficiency virus type ## (HIV-##) infection in adults with multidrug resistant HIV-## infecti

  • Ambulatory Care
  • Healthcare
  • Therapy
  • United States
  • Capricor Therapeutics, Inc.

GOVERNMENT S INITIATIVE TO DELIVER LIFE-SAVING SERVICES AND IMPROVE THE LIVES OF THOSE LIVING WITH HIV/ AIDS AROUND THE WORLD.

  • Ambulatory Care
  • Clinical Trial
  • Medical Device
  • United States
  • Company